149 related articles for article (PubMed ID: 20941527)
1. Prodrugs of aza nucleosides based on proton transfer reaction.
Karaman R
J Comput Aided Mol Des; 2010 Dec; 24(12):961-70. PubMed ID: 20941527
[TBL] [Abstract][Full Text] [Related]
2. Computationally designed prodrugs of statins based on Kirby's enzyme model.
Karaman R; Amly W; Scrano L; Mecca G; Bufo SA
J Mol Model; 2013 Sep; 19(9):3969-82. PubMed ID: 23835602
[TBL] [Abstract][Full Text] [Related]
3. Computer-assisted design of pro-drugs for antimalarial atovaquone.
Karaman R; Hallak H
Chem Biol Drug Des; 2010 Oct; 76(4):350-60. PubMed ID: 20731669
[TBL] [Abstract][Full Text] [Related]
4. Prodrugs of acyclovir--a computational approach.
Karaman R; Dajani KK; Qtait A; Khamis M
Chem Biol Drug Des; 2012 May; 79(5):819-34. PubMed ID: 22260647
[TBL] [Abstract][Full Text] [Related]
5. Computer-assisted design for paracetamol masking bitter taste prodrugs.
Hejaz H; Karaman R; Khamis M
J Mol Model; 2012 Jan; 18(1):103-14. PubMed ID: 21491187
[TBL] [Abstract][Full Text] [Related]
6. Computer-assisted design for atenolol prodrugs for the use in aqueous formulations.
Karaman R; Dajani K; Hallak H
J Mol Model; 2012 Apr; 18(4):1523-40. PubMed ID: 21785934
[TBL] [Abstract][Full Text] [Related]
7. Design, synthesis, and in vitro kinetics study of atenolol prodrugs for the use in aqueous formulations.
Karaman R; Qtait A; Dajani KK; Abu Lafi S
ScientificWorldJournal; 2014; 2014():248651. PubMed ID: 24526887
[TBL] [Abstract][Full Text] [Related]
8. The euphoria of hypomethylating agents in MDS and AML: is it justified?
Sekeres MA
Best Pract Res Clin Haematol; 2013 Sep; 26(3):275-8. PubMed ID: 24309530
[TBL] [Abstract][Full Text] [Related]
9. Decitabine versus 5-azacitidine for the treatment of myelodysplastic syndrome: adjusted indirect meta-analysis.
Kumar A; List AF; Hozo I; Komrokji R; Djulbegovic B
Haematologica; 2010 Feb; 95(2):340-2; author reply 343-4. PubMed ID: 19850902
[No Abstract] [Full Text] [Related]
10. Comparative clinical effectiveness of azacitidine versus decitabine in older patients with myelodysplastic syndromes.
Zeidan AM; Davidoff AJ; Long JB; Hu X; Wang R; Ma X; Gross CP; Abel GA; Huntington SF; Podoltsev NA; Hajime U; Prebet T; Gore SD
Br J Haematol; 2016 Dec; 175(5):829-840. PubMed ID: 27650975
[TBL] [Abstract][Full Text] [Related]
11. Decitabine.
Gore SD; Jones C; Kirkpatrick P
Nat Rev Drug Discov; 2006 Nov; 5(11):891-2. PubMed ID: 17117522
[No Abstract] [Full Text] [Related]
12. Epigenetic therapy of cancer with 5-aza-2'-deoxycytidine (decitabine).
Momparler RL
Semin Oncol; 2005 Oct; 32(5):443-51. PubMed ID: 16210084
[TBL] [Abstract][Full Text] [Related]
13. Epigenetic therapy with decitabine for myelodysplasia and leukemia.
Wijermans P; Lübert M
Future Oncol; 2005 Oct; 1(5):585-91. PubMed ID: 16556035
[TBL] [Abstract][Full Text] [Related]
14. Lack of objective response of myelodysplastic syndromes and acute myeloid leukemia to decitabine after failure of azacitidine.
Duong VH; Bhatnagar B; Zandberg DP; Vannorsdall EJ; Tidwell ML; Chen Q; Baer MR
Leuk Lymphoma; 2015 Jun; 56(6):1718-22. PubMed ID: 25263320
[TBL] [Abstract][Full Text] [Related]
15. Comparison between decitabine and azacitidine for the treatment of myelodysplastic syndrome: a meta-analysis with 1,392 participants.
Xie M; Jiang Q; Xie Y
Clin Lymphoma Myeloma Leuk; 2015 Jan; 15(1):22-8. PubMed ID: 25042977
[TBL] [Abstract][Full Text] [Related]
16. Clinical Impact of Hypomethylating Agents in the Treatment of Myelodysplastic Syndromes.
Finelli C; Follo MY; Stanzani M; Parisi S; Clissa C; Mongiorgi S; Barraco M; Cocco L
Curr Pharm Des; 2016; 22(16):2349-57. PubMed ID: 26960675
[TBL] [Abstract][Full Text] [Related]
17. Decitabine in myelodysplastic syndromes: viewpoints.
Garcia-Manero G; Saba HI
Drugs; 2006; 66(7):959-60. PubMed ID: 16740015
[No Abstract] [Full Text] [Related]
18. Cytogenetic responses in high-risk myelodysplastic syndrome following low-dose treatment with the DNA methylation inhibitor 5-aza-2'-deoxycytidine.
Lübbert M; Wijermans P; Kunzmann R; Verhoef G; Bosly A; Ravoet C; Andre M; Ferrant A
Br J Haematol; 2001 Aug; 114(2):349-57. PubMed ID: 11529854
[TBL] [Abstract][Full Text] [Related]
19. Enzyme Models-From Catalysis to Prodrugs.
Breijyeh Z; Karaman R
Molecules; 2021 May; 26(11):. PubMed ID: 34071328
[TBL] [Abstract][Full Text] [Related]
20. Decitabine in the Treatment of Acute Myeloid Leukemia and Myelodysplastic Syndromes, Which Combined with Complex Karyotype Respectively.
Gao S; Li Z; Fu JH; Hu XH; Xu Y; Jin ZM; Tang XW; Han Y; Chen SN; Sun AN; Wu DP; Qiu HY
Asian Pac J Cancer Prev; 2015; 16(15):6627-32. PubMed ID: 26434886
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
